The origin of endothelin-1 in patients with severe preeclampsia

Orion A. Rust, James A. Bofill, Dion H. Zappe, John E. Hall, John C Jr. Burnett, James N. Martin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: To determine the site of origin of increased concentrations of plasma endothelin-1 in patients with severe preeclampsia. Methods: Twelve patients with severe preeclampsia undergoing an indicated abdominal delivery had endothelin-1 levels measured from plasma specimens drawn from right and left uterine and antecubital veins before delivery and after placenta removal with uterine curettage. Twelve uncomplicated control patients undergoing abdominal delivery had endothelin-1 concentrations drawn by an identical protocol. Clinical staff members were blinded to endothelin-1 results and laboratory staff were blinded to patient group assignment and sample source. Endothelin-1 plasma concentrations were determined by radioimmunoassay and data were analyzed by paired t test. Results: No difference in endothelin-1 concentration was noted with respect to placental location, central versus peripheral, or predelivery versus postdelivery sampling procedures. Overall, patients with preeclampsia had higher plasma concentrations of endothelin-1 (mean 11.0 ± 6.6 pg/mL) compared with normotensive patients (mean 8.4 ± 6.7 pg/mL, P < .005). Conclusion: The decidual-placental interface does not appear to be the source of increased plasma endothelin-1 concentrations found in severe preeclampsia. The origin of this increase remains uncertain.

Original languageEnglish (US)
Pages (from-to)754-757
Number of pages4
JournalObstetrics and Gynecology
Volume89
Issue number5 I
DOIs
StatePublished - May 1997

Fingerprint

Endothelin-1
Pre-Eclampsia
Cesarean Section
Curettage
Placenta
Radioimmunoassay
Veins

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The origin of endothelin-1 in patients with severe preeclampsia. / Rust, Orion A.; Bofill, James A.; Zappe, Dion H.; Hall, John E.; Burnett, John C Jr.; Martin, James N.

In: Obstetrics and Gynecology, Vol. 89, No. 5 I, 05.1997, p. 754-757.

Research output: Contribution to journalArticle

Rust, OA, Bofill, JA, Zappe, DH, Hall, JE, Burnett, JCJ & Martin, JN 1997, 'The origin of endothelin-1 in patients with severe preeclampsia', Obstetrics and Gynecology, vol. 89, no. 5 I, pp. 754-757. https://doi.org/10.1016/S0029-7844(97)00093-8
Rust, Orion A. ; Bofill, James A. ; Zappe, Dion H. ; Hall, John E. ; Burnett, John C Jr. ; Martin, James N. / The origin of endothelin-1 in patients with severe preeclampsia. In: Obstetrics and Gynecology. 1997 ; Vol. 89, No. 5 I. pp. 754-757.
@article{16332cdf9d75463ab2bb494bcf5e83ae,
title = "The origin of endothelin-1 in patients with severe preeclampsia",
abstract = "Objective: To determine the site of origin of increased concentrations of plasma endothelin-1 in patients with severe preeclampsia. Methods: Twelve patients with severe preeclampsia undergoing an indicated abdominal delivery had endothelin-1 levels measured from plasma specimens drawn from right and left uterine and antecubital veins before delivery and after placenta removal with uterine curettage. Twelve uncomplicated control patients undergoing abdominal delivery had endothelin-1 concentrations drawn by an identical protocol. Clinical staff members were blinded to endothelin-1 results and laboratory staff were blinded to patient group assignment and sample source. Endothelin-1 plasma concentrations were determined by radioimmunoassay and data were analyzed by paired t test. Results: No difference in endothelin-1 concentration was noted with respect to placental location, central versus peripheral, or predelivery versus postdelivery sampling procedures. Overall, patients with preeclampsia had higher plasma concentrations of endothelin-1 (mean 11.0 ± 6.6 pg/mL) compared with normotensive patients (mean 8.4 ± 6.7 pg/mL, P < .005). Conclusion: The decidual-placental interface does not appear to be the source of increased plasma endothelin-1 concentrations found in severe preeclampsia. The origin of this increase remains uncertain.",
author = "Rust, {Orion A.} and Bofill, {James A.} and Zappe, {Dion H.} and Hall, {John E.} and Burnett, {John C Jr.} and Martin, {James N.}",
year = "1997",
month = "5",
doi = "10.1016/S0029-7844(97)00093-8",
language = "English (US)",
volume = "89",
pages = "754--757",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5 I",

}

TY - JOUR

T1 - The origin of endothelin-1 in patients with severe preeclampsia

AU - Rust, Orion A.

AU - Bofill, James A.

AU - Zappe, Dion H.

AU - Hall, John E.

AU - Burnett, John C Jr.

AU - Martin, James N.

PY - 1997/5

Y1 - 1997/5

N2 - Objective: To determine the site of origin of increased concentrations of plasma endothelin-1 in patients with severe preeclampsia. Methods: Twelve patients with severe preeclampsia undergoing an indicated abdominal delivery had endothelin-1 levels measured from plasma specimens drawn from right and left uterine and antecubital veins before delivery and after placenta removal with uterine curettage. Twelve uncomplicated control patients undergoing abdominal delivery had endothelin-1 concentrations drawn by an identical protocol. Clinical staff members were blinded to endothelin-1 results and laboratory staff were blinded to patient group assignment and sample source. Endothelin-1 plasma concentrations were determined by radioimmunoassay and data were analyzed by paired t test. Results: No difference in endothelin-1 concentration was noted with respect to placental location, central versus peripheral, or predelivery versus postdelivery sampling procedures. Overall, patients with preeclampsia had higher plasma concentrations of endothelin-1 (mean 11.0 ± 6.6 pg/mL) compared with normotensive patients (mean 8.4 ± 6.7 pg/mL, P < .005). Conclusion: The decidual-placental interface does not appear to be the source of increased plasma endothelin-1 concentrations found in severe preeclampsia. The origin of this increase remains uncertain.

AB - Objective: To determine the site of origin of increased concentrations of plasma endothelin-1 in patients with severe preeclampsia. Methods: Twelve patients with severe preeclampsia undergoing an indicated abdominal delivery had endothelin-1 levels measured from plasma specimens drawn from right and left uterine and antecubital veins before delivery and after placenta removal with uterine curettage. Twelve uncomplicated control patients undergoing abdominal delivery had endothelin-1 concentrations drawn by an identical protocol. Clinical staff members were blinded to endothelin-1 results and laboratory staff were blinded to patient group assignment and sample source. Endothelin-1 plasma concentrations were determined by radioimmunoassay and data were analyzed by paired t test. Results: No difference in endothelin-1 concentration was noted with respect to placental location, central versus peripheral, or predelivery versus postdelivery sampling procedures. Overall, patients with preeclampsia had higher plasma concentrations of endothelin-1 (mean 11.0 ± 6.6 pg/mL) compared with normotensive patients (mean 8.4 ± 6.7 pg/mL, P < .005). Conclusion: The decidual-placental interface does not appear to be the source of increased plasma endothelin-1 concentrations found in severe preeclampsia. The origin of this increase remains uncertain.

UR - http://www.scopus.com/inward/record.url?scp=0031000068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031000068&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(97)00093-8

DO - 10.1016/S0029-7844(97)00093-8

M3 - Article

C2 - 9166315

AN - SCOPUS:0031000068

VL - 89

SP - 754

EP - 757

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5 I

ER -